Estrella Immunopharma (ESLA)
NASDAQ:ESLA
US Market
Holding ESLA?
Track your performance easily

Estrella Immunopharma (ESLA) Financial Statements

22 Followers

Estrella Immunopharma Financial Overview

Estrella Immunopharma's market cap is currently ―. The company's EPS TTM is $-1.927; its P/E ratio is -0.41; Estrella Immunopharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 469.53K-$ -1.87M$ -54.93K$ -43.86K
EBITDA$ 469.53K-$ -1.87M$ -54.93K$ -43.86K
Net Income Common Stockholders$ -469.53K-$ -1.87M$ -76.00K$ -63.30K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.73M$ 9.05M$ 22.14M$ 0.00$ 29.39K
Total Assets$ 8.63M$ 9.45M$ 27.35M$ 9.92M$ 9.78M
Total Debt$ 0.00$ 0.00$ 300.00K$ 273.07K$ 136.53K
Net Debt$ -4.73M$ -9.05M$ -21.84M$ 273.07K$ 107.14K
Total Liabilities$ 138.49K$ 398.73K$ 17.28M$ 2.99M$ 2.77M
Stockholders Equity$ 8.49M$ 9.05M$ 10.07M$ -2.82M$ -2.53M
Cash Flow-
Free Cash Flow--$ -275.19K$ -212.67K$ -275.72K
Operating Cash Flow$ -15.78M$ -11.27M$ -275.19K$ -212.67K$ -275.72K
Investing Cash Flow$ 4.96M$ 5.07M$ -112.30K$ 21.43K$ 77.77K
Financing Cash Flow$ 13.06M$ -6.90M$ 20.05M$ 196.53K$ 186.53K
Currency in USD

Estrella Immunopharma Earnings and Revenue History

Estrella Immunopharma Debt to Assets

Estrella Immunopharma Cash Flow

Estrella Immunopharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis